Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-β for GSTA2 gene transactivation

Molecular Pharmacology

Volumn 69, Issue 1, 2006, Pages 385-396

  Seung, Jin Lee ^a   Sang, Geon Kim ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP; OLTIPRAZ; P90 RIBOSOMAL S6 KINASE 1; S6 KINASE; SERINE; SMALL INTERFERING RNA; THREONINE; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CELL FRACTIONATION; CELL NUCLEUS; CELL STRAIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DOMINANT GENE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION; GENE MUTATION; GENE TRANSLOCATION; GENETIC TRANSFECTION; GSTA2 GENE TRANSACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PYRAZINES; RATS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 30044447192     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.018465     Document Type: Article

References (40)

1. Bhatt RR and Ferrell JE Jr (1999) The protein kinase p90 RSK as an essential mediator of cytostatic factor activity. Science (Wash DC) 286:1362-1365.
2. Bolton MG, Munoz A, Jacobson LP, Groopman JD, Maxuitenko YY, Roebuck BD, and Kensler TW (1993) Transient intervention with oltipraz against aflatoxin-induced hepatic tumorigenesis. Cancer Res 53:3499-3504.
3. Buck M and Chojkier M (2003) Signal transduction in the liver: C/EBPβ modulates cell proliferation and survival. Hepatology 37:731-738.
4. Buck M, Poli V, Hunter T, and Chojkier M (2001) C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 8:807-816.
5. Buck M, Poli V, van der Geer P, Chojkier M, and Hunter T (1999) Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFα. Mol Cell 4:1087-1092.
6. Casamayor A, Morrice NA, and Alessi DR (1999) Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 342:287-292.
7. Chen RH, Abate C, and Blenis J (1993) Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci USA 90:10952-10956.
8. Cho IJ and Kim SG (2003a) Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation. J Biol Chem 278:44103-44112.
9. Cho MK and Kim SG (2003b) Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway. Hepatology 37:686-695.
10. Diehl AM (1998) Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. J Biol Chem 273:30843-30846.
11. Duong DT, Waltner-Law ME, Sears R, Sealy L, and Granner DK (2002) Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 277:32234-32242.
12. Frodin M and Gammeltoft S (1999) Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151:65-77.
13. Ghoda L, Lin X, and Greene WC (1997) The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J Biol Chem 272:21281-21288.
14. Gross SD, Schwab MS, Lewellyn AL, and Maller JL (1999) Induction of metaphase arrest in cleaving Xenopus embryos by the protein kinase p90 RSK. Science (Wash DC) 286:1365-1367.
15. Hanlon M, Sturgill TW, and Sealy L (2001) ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor. J Biol Chem 276:38449-38456.
16. Jacobson LP, Zhang BC, Zhu YR, Wang JB, Wu Y, Zhang QN, Yu LY, Qian GS, Kuang SY, Li YF, et al. (1997) Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6:257-265.
17. Jensen CJ, Buch MB, Krag TO, Hemmings BA, Gammeltoft S, and Frodin M (1999) 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J Biol Chem 274:27168-27176.
18. Kang KW, Cho IJ, Lee CH, and Kim SG (2003) Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz. J Natl Cancer Inst 95:53-66.
19. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, and Waterfield MD (2001) Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis and cancer. Annu Rev Cell Dev Biol 17:615-675.
20. Kensler TW (1997) Chemoprevention by inducers of carcinogen detoxication enzymes. Environ Health Perspect 105:965-970.
21. Mink S, Haenig B, and Klempnauer KH (1997) Interaction and functional collaboration of p300 and C/EBPβ. Mol Cell Biol 17:6609-6617.
22. Mink S, Jaswal S, Burk O, and Klempnauer KH (1999) The v-Myb oncoprotein activates C/EBPβ expression by stimulating an autoregulatory loop at the C/EBPβ promoter. Biochim Biophys Acta 1447:175-184.
23. Moller DE, Xia CH, Tang W, Zhu AX, and Jakubowski M (1994) Human RSK isoforms: cloning and characterization of tissue-specific expression. Am J Physiol 266:C351-C359.
24. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, and Akira S (1993) Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 90:2207-2211.
25. Park EY, Cho IJ, and Kim SG (2004) Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-γ and retinoid X receptor heterodimer. Cancer Res 64:3701-3713.
26. Rao CV, Rivenson A, Katiwalla M, Kelloff GJ, and Reddy BS (1993) Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res 53:2502-2606.
27. Richards SA, Dreisbach VC, Murphy LO, and Blenis J (2001) Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1. Mol Cell Biol 21:7470-7480.
28. Richards SA, Fu J, Romanelli A, Shimamura A, and Blenis J (1999) Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK. Curr Biol 9:810-820.
29. Roebuck BD, Liu YL, Rogers AE, Groopman JD, and Kensler TW (1991) Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res 51:5501-5506.
30. Roux PP, Richards SA, and Blenis J (2003) Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol Cell Biol 23:4796-4804.
31. Ruggeri BA, Robinson C, Angeles T, Wilkinson J 4th, and Clapper ML (2002) The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo and in vivo and inhibits tumor xenograft growth. Clin Cancer Res 8:267-274.
32. Schouten GJ, Vertegaal AC, Whiteside ST, Israel A, Toebes M, Dorsman JC, van der Eb AJ, and Zantema A (1997) IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO (Eur Mol Biol Organ) J 16:3133-3144.
33. Shah BH, Farshori MP, Jambusaria A, and Catt KJ (2003) Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J Biol Chem 278:19118-19126.
34. Shuman JD, Sebastian T, Kaldis P, Copeland TD, Zhu S, Smart RC, and Johnson PF (2004) Cell cycle-dependent phosphorylation of C/EBPβ mediates oncogenic cooperativity between C/EBPβ and H-RasV12. Mol Cell Biol 24:7380-7391.
35. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, and Chojkier M (1993) Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature (Lond) 364:544-547.
36. Trautwein C, van der Geer P, Karin M, Hunter T, and Chojkier M (1994) Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements. J Clin Investig 93:2554-2561.
37. Vik TA and Ryder JW (1997) Identification of serine 380 as the major site of autophosphorylation of Xenopus pp90rsk. Biochem Biophys Res Commun 235:398-402.
38. Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A, Egner PA, et al. (1999) Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 91:347-354.
39. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P, and Alessi DR (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10:439-448.
40. Xing J, Ginty DD, and Greenberg ME (1996) Coupling of the Ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science (Wash DC) 273:959-963.